The Wellthy Diabetes smartphone app was launched at a conference held by the Maharashtra chapter of the Research Society for the Study of Diabetes in India. The 16-week diabetes intervention programme delivered through the mobile app will now be available for doctors in Mumbai to prescribe to their patients. The app uses patient-centric design augmented by artificial intelligence to provide integrated care that complements the doctor consultation. Results from several clinical pilot studies, published in leading scientific journals, have shown that patients with Type II diabetes who complete the programme reduce their HbA1C by more than 1% on average, lose significant weight, and improve their medication and diagnostic adherence.